Mesna
Mesna (brand name Mesnex) is a prescription medication used to protect the bladder from damage caused by chemotherapy drugs like ifosfamide or cyclophosphamide. It is administered intravenously as a 100 mg/mL injection solution by Baxter Healthcare Corporation. This information was generated using AI and is provided for informational and research purposes only.
Find Related Datasets
Search by Tags
Click any tag below to search for similar datasets
Complete Metadata
| @type | dcat:Dataset |
|---|---|
| accessLevel | public |
| accrualPeriodicity | R/P1Y |
| bureauCode |
[
"009:10"
]
|
| contactPoint |
{
"fn": "Division of Drug Information",
"@type": "vcard:Contact",
"hasEmail": "mailto:druginfo@fda.hhs.gov"
}
|
| description | Mesna (brand name Mesnex) is a prescription medication used to protect the bladder from damage caused by chemotherapy drugs like ifosfamide or cyclophosphamide. It is administered intravenously as a 100 mg/mL injection solution by Baxter Healthcare Corporation. This information was generated using AI and is provided for informational and research purposes only. |
| distribution |
[
{
"@type": "dcat:Distribution",
"title": "Mesna",
"mediaType": "text/html",
"description": "
Access the FDA dataset for Mesna — ANDA 218871 submitted by Mylan Institutional LLC
",
"downloadURL": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=218871"
}
]
|
| identifier | ANDA218871 |
| issued | 2016-09-16 |
| keyword |
[
"drug",
"drug-safety",
"fda",
"medications",
"public-health"
]
|
| landingPage | https://www.fda.gov/drugs |
| license | https://open.fda.gov/license |
| modified | 2025-03-17 |
| programCode |
[
"009:002"
]
|
| publisher |
{
"name": "U.S. Food and Drug Administration",
"@type": "org:Organization"
}
|
| theme |
[
"FDA"
]
|
| title | Mesna |
